BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22971284)

  • 1. [Biological function explore of protein CCL15 in HCC cell lines].
    Li YG; Zhang P
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):372-6. PubMed ID: 22971284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL15/CCR1 axis is involved in hepatocellular carcinoma cells migration and invasion.
    Li Y; Wu J; Zhang P
    Tumour Biol; 2016 Apr; 37(4):4501-7. PubMed ID: 26501423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma.
    Li Y; Wang C; Zhao T; Cui R; Hu L; Chang L; Wei X; Zhang J; Li Y
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2198-2203. PubMed ID: 33653254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of serum response factor in hepatocellular carcinoma: an association with matrix metalloproteinase.
    Kim KR; Bae JS; Choi HN; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2011 Dec; 26(6):1567-72. PubMed ID: 21842128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
    Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma.
    Li Y; Yu HP; Zhang P
    Hepatol Int; 2016 May; 10(3):488-92. PubMed ID: 26643668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
    Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of PRL-3 expression, and its correlation with angiogenesis and invasion in hepatocellular carcinoma.
    Zhao WB; Li Y; Liu X; Zhang LY; Wang X
    Int J Mol Med; 2008 Aug; 22(2):187-92. PubMed ID: 18636172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
    Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
    Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2].
    Xiao ZY; Wang YD; Chen XP
    Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
    Liu LZ; Zhang Z; Zheng BH; Shi Y; Duan M; Ma LJ; Wang ZC; Dong LQ; Dong PP; Shi JY; Zhang S; Ding ZB; Ke AW; Cao Y; Zhang XM; Xi R; Zhou J; Fan J; Wang XY; Gao Q
    Hepatology; 2019 Jan; 69(1):143-159. PubMed ID: 30070719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
    Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
    Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of enhanced invasiveness of human hepatocellular carcinoma by integrin alpha 6 beta 1].
    Lu Y; Zhou R
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):287-9. PubMed ID: 11778551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.
    Kanno K; Kanno S; Nitta H; Uesugi N; Sugai T; Masuda T; Wakabayashi G; Maesawa C
    Oncol Rep; 2012 Sep; 28(3):867-73. PubMed ID: 22766642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro.
    Xia D; Yan LN; Xie JG; Tong Y; Yan ML; Wang XP; Zhang MM; Zhao LY
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):409-15. PubMed ID: 16911941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line.
    Wang GL; Chen L; Wei YZ; Zhou JM; Wu YY; Zhang YX; Qin J; Zhu YY
    Oncol Rep; 2012 Jun; 27(6):1944-52. PubMed ID: 22378020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
    Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
    J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.